{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T23:35:20Z","timestamp":1789601720992,"version":"build-2803163510"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T00:00:00Z","timestamp":1674691200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008868","name":"Jiangsu Science and Technology Department","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008868","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011789","name":"Jilin Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["20130727054YY"],"award-info":[{"award-number":["20130727054YY"]}],"id":[{"id":"10.13039\/501100011789","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011789","name":"Jilin Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["20180311072YY"],"award-info":[{"award-number":["20180311072YY"]}],"id":[{"id":"10.13039\/501100011789","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015800","name":"Jilin Province Development and Reform Commission","doi-asserted-by":"publisher","award":["2014N149"],"award-info":[{"award-number":["2014N149"]}],"id":[{"id":"10.13039\/100015800","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.biopha.2023.114304","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T06:41:15Z","timestamp":1675060875000},"page":"114304","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["A novel estrogen-targeted PEGylated liposome co-delivery oxaliplatin and paclitaxel for the treatment of ovarian cancer"],"prefix":"10.1016","volume":"160","author":[{"given":"Yizhuo","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihui","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujia","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yucui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongfanghui","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongli","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2023.114304_bib1","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.semcancer.2020.08.017","article-title":"Challenges for immunotherapy for the treatment of platinum resistant ovarian cancer","volume":"77","author":"Le Saux","year":"2021","journal-title":"Semin. Cancer Biol."},{"issue":"10290","key":"10.1016\/j.biopha.2023.114304_bib2","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1016\/S0140-6736(21)00731-5","article-title":"Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial","volume":"397","author":"Menon","year":"2021","journal-title":"Lancet"},{"issue":"17","key":"10.1016\/j.biopha.2023.114304_bib3","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1200\/JCO.21.00306","article-title":"Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050\/GOG 3015\/ENGOT-OV39)","volume":"39","author":"Moore","year":"2021","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.biopha.2023.114304_bib4","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrc2644","article-title":"The biology of ovarian cancer: new opportunities for translation","volume":"9","author":"Bast","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2023.114304_bib5","first-page":"371","article-title":"Treatment of epithelial ovarian cancer","author":"Kuroki","year":"2020","journal-title":"Bmj-Br. Med. J."},{"issue":"5","key":"10.1016\/j.biopha.2023.114304_bib6","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/CM9.0000000000002108","article-title":"Cancer statistics in China and United States, 2022: profiles, trends, and determinants","volume":"135","author":"Xia","year":"2022","journal-title":"Chin. Med. J."},{"issue":"1","key":"10.1016\/j.biopha.2023.114304_bib7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21708","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA-Cancer J. Clin."},{"issue":"5","key":"10.1016\/j.biopha.2023.114304_bib8","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1200\/JCO.2002.20.5.1248","article-title":"Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis","volume":"20","author":"Bristow","year":"2002","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2023.114304_bib9","doi-asserted-by":"crossref","DOI":"10.1038\/s41420-021-00451-x","article-title":"A novel defined pyroptosis-related gene signature for predicting the prognosis of ovarian cancer","volume":"7","author":"Ye","year":"2021","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.biopha.2023.114304_bib10","first-page":"2015","article-title":"Paclitaxel and its evolving role in the management of ovarian cancer","author":"Kampan","year":"2015","journal-title":"BioMed. Res. Int."},{"issue":"1","key":"10.1016\/j.biopha.2023.114304_bib11","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijpharm.2017.11.048","article-title":"Liposomes encapsulating native and cyclodextrin enclosed paclitaxel: Enhanced loading efficiency and its pharmacokinetic evaluation","volume":"536","author":"Bhatt","year":"2018","journal-title":"Int. J. Pharm."},{"issue":"26","key":"10.1016\/j.biopha.2023.114304_bib12","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1056\/NEJMoa1103799","article-title":"A phase 3 trial of bevacizumab in ovarian cancer","volume":"365","author":"Perren","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.biopha.2023.114304_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/polym14040658","article-title":"Paclitaxel drug delivery systems: focus on nanocrystals' surface modifications","volume":"14","author":"Haddad","year":"2022","journal-title":"Polymers"},{"issue":"1","key":"10.1016\/j.biopha.2023.114304_bib14","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-021-08722-7","article-title":"Exposure to low intensity ultrasound removes paclitaxel cytotoxicity in breast and ovarian cancer cells","volume":"21","author":"Amaya","year":"2021","journal-title":"Bmc Cancer"},{"key":"10.1016\/j.biopha.2023.114304_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/ijc.34022","article-title":"Survival outcomes for dose-dense paclitaxel plus carboplatin neoadjuvant versus standard adjuvant chemotherapy in stage II to III triple-negative breast cancer: a prospective cohort study with propensity-matched analysis","author":"Xiu","year":"2022","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.biopha.2023.114304_bib16","doi-asserted-by":"crossref","DOI":"10.2217\/nnm-2022-0025","article-title":"Nanoparticle albumin-bound paclitaxel is superior to liposomal paclitaxel in the neoadjuvant treatment of breast cancer","author":"Zhang","year":"2022","journal-title":"Nanomed. (Lond., Engl. )"},{"key":"10.1016\/j.biopha.2023.114304_bib17","first-page":"164","article-title":"Electrospun gold nanorods\/graphene oxide loaded-core-shell nanofibers for local delivery of paclitaxel against lung cancer during photo-chemotherapy method","author":"Azerbaijan","year":"2021","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2023.114304_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.844426","article-title":"Reactive Oxygen Species-Responsive Nanococktail With Self-Amplificated Drug Release for Efficient Co-Delivery of Paclitaxel\/Cucurbitacin B and Synergistic Treatment of Gastric Cancer","volume":"10","author":"Pang","year":"2022","journal-title":"Front. Chem."},{"issue":"20","key":"10.1016\/j.biopha.2023.114304_bib19","doi-asserted-by":"crossref","first-page":"5891","DOI":"10.1158\/0008-5472.CAN-17-3480","article-title":"Paclitaxel reduces tumor growth by reprogramming tumor-associated macrophages to an M1 profile in a TLR4-dependent manner","volume":"78","author":"Wanderley","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2023.114304_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2018.10.032","article-title":"Co-delivery of paclitaxel and cisplatin in poly(2-oxazoline) polymeric micelles: Implications for drug loading, release, pharmacokinetics and outcome of ovarian and breast cancer treatments","volume":"192","author":"Wan","year":"2019","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.biopha.2023.114304_bib21","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s10565-018-09450-8","article-title":"Studies on combination of oxaliplatin and dendrosomal nanocurcumin on proliferation, apoptosis induction, and long non-coding RNA expression in ovarian cancer cells","volume":"35","author":"Hosseini","year":"2019","journal-title":"Cell Biol. Toxicol."},{"issue":"5","key":"10.1016\/j.biopha.2023.114304_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12073","article-title":"Small extracellular vesicles ameliorate peripheral neuropathy and enhance chemotherapy of oxaliplatin on ovarian cancer","volume":"10","author":"Zhang","year":"2021","journal-title":"J. Extracell. Vesicles"},{"issue":"1","key":"10.1016\/j.biopha.2023.114304_bib23","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-021-09027-5","article-title":"Oxaliplatin plus S-1 with intraperitoneal paclitaxel for the treatment of Chinese advanced gastric cancer with peritoneal metastases","volume":"21","author":"Shi","year":"2021","journal-title":"Bmc Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2023.114304_bib24","article-title":"Downregulation of MEIS1 mediated by ELFN1-AS1\/EZH2\/DNMT3a axis promotes tumorigenesis and oxaliplatin resistance in colorectal cancer","volume":"7","author":"Li","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"2","key":"10.1016\/j.biopha.2023.114304_bib25","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s40199-020-00374-5","article-title":"Development, optimization and in vitro evaluation of oxaliplatin loaded nanoparticles in non-small cell lung cancer","volume":"28","author":"Esim","year":"2020","journal-title":"Daru-J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2023.114304_bib26","first-page":"163","article-title":"In vitro and in vivo combinatorial anticancer effects of oxaliplatin- and resveratrol-loaded N,O-carboxymethyl chitosan nanoparticles against colorectal cancer","author":"Wang","year":"2021","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2023.114304_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119397","article-title":"Behavior and electrophysiology studies of the peripheral neuropathy induced by individual and co-administration of paclitaxel and oxaliplatin in rat","volume":"277","author":"Paniagua","year":"2021","journal-title":"Life Sci."},{"issue":"12","key":"10.1016\/j.biopha.2023.114304_bib28","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1002\/cam4.897","article-title":"Long-term results of definitive concurrent chemoradiotherapy using paclitaxel plus oxaliplatin in unresectable locally advanced esophageal cancer: a prospective phase II trial","volume":"5","author":"Song","year":"2016","journal-title":"Cancer Med."},{"issue":"6","key":"10.1016\/j.biopha.2023.114304_bib29","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s00280-018-3576-x","article-title":"Combination chemotherapy with paclitaxel and oxaliplatin as first-line treatment in patients with advanced gastric cancer","volume":"81","author":"Lan","year":"2018","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2023.114304_bib30","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nrc.2016.108","article-title":"Cancer nanomedicine: progress, challenges and opportunities","volume":"17","author":"Shi","year":"2017","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.biopha.2023.114304_bib31","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"- The first FDA-approved nano-drug: Lessons learned","volume":"160","author":"Barenholz","year":"2012","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.biopha.2023.114304_bib32","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nrc.2016.108","article-title":"Cancer nanomedicine: progress, challenges and opportunities","volume":"17","author":"Shi","year":"2017","journal-title":"Nat. Rev. Cancer"},{"issue":"19","key":"10.1016\/j.biopha.2023.114304_bib33","doi-asserted-by":"crossref","first-page":"10938","DOI":"10.1021\/acs.chemrev.5b00046","article-title":"New developments in liposomal drug delivery","volume":"115","author":"Pattni","year":"2015","journal-title":"Chem. Rev."},{"key":"10.1016\/j.biopha.2023.114304_bib34","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.addr.2017.07.007","article-title":"Pharmacological and physical vessel modulation strategies to improve EPR-mediated drug targeting to tumors","volume":"119","author":"Ojha","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2023.114304_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19010195","article-title":"Surface functionalization and targeting strategies of liposomes in solid tumor therapy: a review","volume":"19","author":"Riaz","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.biopha.2023.114304_bib36","doi-asserted-by":"crossref","first-page":"17348","DOI":"10.1021\/acsnano.1c05165","article-title":"Imaging strategy that achieves ultrahigh contrast by utilizing differential esterase activity in organs: application in early detection of pancreatic cancer","volume":"15","author":"Lee","year":"2021","journal-title":"Acs Nano"},{"issue":"3","key":"10.1016\/j.biopha.2023.114304_bib37","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1021\/acsnano.9b08133","article-title":"Nanomaterials for nanotheranostics: tuning their properties according to disease needs","volume":"14","author":"Wong","year":"2020","journal-title":"Acs Nano"},{"key":"10.1016\/j.biopha.2023.114304_bib38","first-page":"9","article-title":"Cloaking nanoparticles with protein corona shield for targeted drug delivery","author":"Oh","year":"2018","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biopha.2023.114304_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1248\/bpb.b16-00624","article-title":"Liposomal delivery systems: design optimization and current applications","volume":"40","author":"Abu Lila","year":"2017","journal-title":"Biol. Pharm. Bull."},{"issue":"1","key":"10.1016\/j.biopha.2023.114304_bib40","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1080\/10717544.2021.1905749","article-title":"In vitro and in vivo antitumor effects of lupeol-loaded galactosylated liposomes","volume":"28","author":"Zhang","year":"2021","journal-title":"Drug Deliv."},{"key":"10.1016\/j.biopha.2023.114304_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2020.12.011","article-title":"pH-sensitive multi-drug liposomes targeting folate receptor beta for efficient treatment of non-small cell lung cancer","volume":"330","author":"Park","year":"2021","journal-title":"J. Control. Release"},{"issue":"8","key":"10.1016\/j.biopha.2023.114304_bib42","doi-asserted-by":"crossref","first-page":"10102","DOI":"10.1021\/acsami.1c23166","article-title":"Sequential delivery of quercetin and paclitaxel for the fibrotic tumor microenvironment remodeling and chemotherapy potentiation via a dual-targeting hybrid micelle-in-liposome system","volume":"14","author":"Duan","year":"2022","journal-title":"Acs Appl. Mater. Interfaces"},{"issue":"3","key":"10.1016\/j.biopha.2023.114304_bib43","doi-asserted-by":"crossref","DOI":"10.1007\/s11906-020-1022-z","article-title":"Estrogen and Bisphenol A in Hypertension","volume":"22","author":"Wehbe","year":"2020","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.biopha.2023.114304_bib44","first-page":"28","article-title":"Signal Crosstalk and the Role of Estrogen Receptor beta (ER beta) in Prostate Cancer","author":"Li","year":"2022","journal-title":"Med. Sci. Monit."},{"issue":"5","key":"10.1016\/j.biopha.2023.114304_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23052605","article-title":"Estrogen Receptors Mediated Negative Effects of Estrogens and Xenoestrogens in Teleost Fishes-Review","volume":"23","author":"Wojnarowski","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2023.114304_bib46","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1023\/A:1006132427948","article-title":"Steroid hormone receptors in breast cancer management","volume":"51","author":"Osborne","year":"1998","journal-title":"Breast Cancer Res. Treat."},{"issue":"2","key":"10.1016\/j.biopha.2023.114304_bib47","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/modpathol.2008.130","article-title":"Estrogen receptor gene amplification occurs rarely in ovarian cancer","volume":"22","author":"Issa","year":"2009","journal-title":"Mod. Pathol."},{"issue":"1","key":"10.1016\/j.biopha.2023.114304_bib48","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1134\/S1607672918050058","article-title":"Estrogen Receptors alpha and beta in Ovarian Cancer: Expression Level and Prognosis","volume":"482","author":"Bogush","year":"2018","journal-title":"Dokl. Biochem. Biophys."},{"key":"10.1016\/j.biopha.2023.114304_bib49","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jconrel.2021.05.040","article-title":"Low dose shikonin and anthracyclines coloaded liposomes induce robust immunogenetic cell death for synergistic chemo-immunotherapy","volume":"335","author":"Li","year":"2021","journal-title":"J. Control. Release"},{"issue":"8","key":"10.1016\/j.biopha.2023.114304_bib50","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/jphp.12736","article-title":"Oestrone-targeted liposomes for mitoxantrone delivery via oestrogen receptor - synthesis, physicochemical characterization and in-vitro evaluation","volume":"69","author":"Hao","year":"2017","journal-title":"J. Pharm. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2023.114304_bib51","doi-asserted-by":"crossref","DOI":"10.1007\/s40820-020-00472-8","article-title":"One stone four birds: a novel liposomal delivery system multi-functionalized with ginsenoside Rh2 for tumor targeting therapy","volume":"12","author":"Hong","year":"2020","journal-title":"Nano-Micro Lett."},{"key":"10.1016\/j.biopha.2023.114304_bib52","first-page":"10","article-title":"Pharmacokinetic interaction of green rooibos extract with atorvastatin and metformin in rats","author":"Patel","year":"2019","journal-title":"Front Pharm."},{"issue":"5","key":"10.1016\/j.biopha.2023.114304_bib53","doi-asserted-by":"crossref","DOI":"10.1208\/s12249-020-01709-w","article-title":"Pharmacokinetic study of ferulic acid following transdermal or intragastric administration in rats","volume":"21","author":"Yan","year":"2020","journal-title":"Aaps Pharmscitech"},{"key":"10.1016\/j.biopha.2023.114304_bib54","first-page":"2020","article-title":"The effect of grapefruit juice on the pharmacokinetics of tadalafil in rats","author":"Shen","year":"2020","journal-title":"BioMed. Res. Int."},{"issue":"20","key":"10.1016\/j.biopha.2023.114304_bib55","doi-asserted-by":"crossref","first-page":"9402","DOI":"10.1039\/D1NR00950H","article-title":"Collagenase-loaded pH-sensitive nanocarriers efficiently remodeled tumor stroma matrixes and improved the enrichment of nanomedicines","volume":"13","author":"Wang","year":"2021","journal-title":"Nanoscale"},{"issue":"2","key":"10.1016\/j.biopha.2023.114304_bib56","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0304-4157(92)90038-C","article-title":"Sterically stabilized liposomes","volume":"1113","author":"Woodle","year":"1992","journal-title":"Biochim. Et. Biophys. Acta"},{"key":"10.1016\/j.biopha.2023.114304_bib57","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.actbio.2021.03.055","article-title":"Liposome technologies towards colorectal cancer therapeutics","volume":"127","author":"Sang","year":"2021","journal-title":"Acta Biomater."},{"issue":"20","key":"10.1016\/j.biopha.2023.114304_bib58","doi-asserted-by":"crossref","first-page":"5886","DOI":"10.7150\/thno.32416","article-title":"Co-delivery of VEGF siRNA and Etoposide for Enhanced Anti-angiogenesis and Anti-proliferation Effect via Multi-functional Nanoparticles for Orthotopic Non-Small Cell Lung Cancer Treatment","volume":"9","author":"Li","year":"2019","journal-title":"Theranostics"},{"issue":"4","key":"10.1016\/j.biopha.2023.114304_bib59","doi-asserted-by":"crossref","DOI":"10.1007\/s10856-015-5487-2","article-title":"Skin targeted lipid vesicles as novel nano-carrier of ketoconazole: characterization, in vitro and in vivo evaluation","volume":"26","author":"Guo","year":"2015","journal-title":"J. Mater. Sci. -Mater. Med."},{"issue":"9","key":"10.1016\/j.biopha.2023.114304_bib60","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26092591","article-title":"Nanoformulation and evaluation of oral berberine-loaded liposomes","volume":"26","author":"Duong","year":"2021","journal-title":"Molecules"},{"issue":"30","key":"10.1016\/j.biopha.2023.114304_bib61","doi-asserted-by":"crossref","first-page":"7621","DOI":"10.1021\/acs.langmuir.6b01339","article-title":"Discrimination of proteins using an array of surfactant-stabilized gold nanoparticles","volume":"32","author":"Rogowski","year":"2016","journal-title":"Langmuir"},{"issue":"1","key":"10.1016\/j.biopha.2023.114304_bib62","doi-asserted-by":"crossref","DOI":"10.1208\/s12248-021-00652-3","article-title":"Zwitterionic polymer coatings enhance gold nanoparticle stability and uptake in various biological environments","volume":"24","author":"King","year":"2022","journal-title":"Aaps J."},{"issue":"1","key":"10.1016\/j.biopha.2023.114304_bib63","doi-asserted-by":"crossref","DOI":"10.1208\/s12249-020-01890-y","article-title":"Preparation, Characterization, and In Vitro Pharmacodynamics and Pharmacokinetics Evaluation of PEGylated Urolithin A Liposomes","volume":"22","author":"Yi","year":"2021","journal-title":"Aaps Pharmscitech"},{"issue":"6","key":"10.1016\/j.biopha.2023.114304_bib64","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a016758","article-title":"Clathrin-independent pathways of endocytosis","volume":"6","author":"Mayor","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"8","key":"10.1016\/j.biopha.2023.114304_bib65","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nrm2216","article-title":"Pathways of clathrin-independent endocytosis","volume":"8","author":"Mayor","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223000926?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223000926?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T11:41:27Z","timestamp":1776771687000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223000926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":65,"alternative-id":["S0753332223000926"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.114304","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel estrogen-targeted PEGylated liposome co-delivery oxaliplatin and paclitaxel for the treatment of ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.114304","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"114304"}}